LPCN LIPOCINE INC NEW

Ownership history in VANGUARD GROUP INC  ·  11 quarters on record

This page tracks every 13F SEC filing in which VANGUARD GROUP INC reported a position in LIPOCINE INC NEW (LPCN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 221,867 0% 0.00% $1.8M $8.03
2025 Q3 REDUCED 221,867 -3,009 -1.3% 0.00% $635K $2.85
2025 Q2 REDUCED 224,876 -1,400 -0.6% 0.00% $711K $3.16
2025 Q1 ADDED 226,276 +4,817 +2.2% 0.00% $720K $3.18
2024 Q4 UNCHANGED 221,459 0% 0.00% $1.1M $4.88
2024 Q3 UNCHANGED 221,459 0% 0.00% $994K $4.49
2024 Q2 UNCHANGED 221,459 0% 0.00% $1.8M $8.24
2024 Q1 UNCHANGED 221,459 0% 0.00% $1.2M $5.20
2023 Q4 UNCHANGED 221,459 0% 0.00% $618K $2.79
2023 Q3 UNCHANGED 221,459 0% 0.00% $660K $2.98
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    LPCN price (monthly, adj. close)
← Back to VANGUARD GROUP INC Holdings